Consistent with our prediction, PKP3 silencing significantly reduced the abundance of the PD-L1 protein and decreased PD-1 binding to the NSCLC cell surface (Fig. 6A-B). The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.